Anti-inflammatory medications and coronary artery disease

被引：0
|
作者：
Jindal, Charulata [1 ]
Buch, Ashesh N. [2 ]
Efird, Jimmy T. [3 ]
机构：
[1] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia
[2] East Carolina Univ, Brody Sch Med, East Carolina Heart Inst, Dept Cardiovasc Sci, Greenville, NC 27858 USA
[3] Duke Univ, Cooperat Studies Program Epidemiol Ctr, Hlth Serv Res & Dev, Affiliated Ctr, Durham, NC 27706 USA
来源：
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2021年 / 28卷 / 02期
关键词：
C-REACTIVE PROTEIN; HEALTHY LIFE-STYLE; PRIMARY PREVENTION; CARDIOVASCULAR-DISEASE; HEART-DISEASE; INFLAMMATION; WOMEN; ATHEROSCLEROSIS; ASPIRIN; GENDER;
D O I：
10.1177/2047487319889719
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：149 / 151
页数：3
相关论文
共 50 条
  • [21] Anti-inflammatory effects of ivabradine in patients with acute coronary syndrome: a pilot study
    Dominguez-Rodriguez, Alberto
    Consuegra-Sanchez, Luciano
    Blanco-Palacios, Gabriela
    Abreu-Gonzalez, Pedro
    Sanchez-Grande, Alejandro
    Bosa-Ojeda, Francisco
    Kaski, Juan Carlos
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 158 (01) : 160 - 162
  • [22] Therapeutic Role of Innovative Anti-Inflammatory Medications in the Prevention of Acute Coronary Syndrome
    Pashun, Raymond Anthony
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2015, 23 (05) : 252 - 260
  • [23] Update on the Inflammatory Hypothesis of Coronary Artery Disease
    Boland, Julia
    Long, Carlin
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (02)
  • [24] Reduced serum levels of vasostatin-2, an anti-inflammatory peptide derived from chromogranin A, are associated with the presence and severity of coronary artery disease
    Lu, Lin
    Wang, Ya Nan
    Li, Ming Chun
    Wang, Hai Bo
    Pu, Li Jin
    Niu, Wen Quan
    Meng, Hua
    Yang, Er Li
    Zhang, Rui Yan
    Zhang, Qi
    Zhao, Qiang
    Chen, Qiu Jing
    De Caterina, Raffaele
    Shen, Wei Feng
    EUROPEAN HEART JOURNAL, 2012, 33 (18) : 2297 - 2306
  • [25] Role of Vascular Inflammation in Coronary Artery Disease: Potential of Anti-inflammatory Drugs in the Prevention of Atherothrombosis
    Moreira, Daniel Medeiros
    da Silva, Roberto Leo
    Vieira, Jefferson Luis
    Fattah, Tammuz
    Lueneberg, Maria Emilia
    Mascia Gottschall, Carlos Antonio
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2015, 15 (01) : 1 - 11
  • [26] Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target population
    Blaum, Christopher
    Brunner, Fabian J.
    Kroeger, Friederike
    Braetz, Julian
    Lorenz, Thiess
    Gossling, Alina
    Ojeda, Francisco
    Koester, Lukas
    Karakas, Mahir
    Zeller, Tanja
    Westermann, Dirk
    Schnabel, Renate
    Blankenberg, Stefan
    Seiffert, Moritz
    Waldeyer, Christoph
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (02) : 152 - 158
  • [27] Association of inflammatory markers with angiographic severity and extent of coronary artery disease
    Drakopoulou, Maria
    Toutouzas, Konstantinos
    Stefanadi, Elli
    Tsiamis, Eleftherios
    Tousoulis, Dimitris
    Stefanadis, Christodoulos
    ATHEROSCLEROSIS, 2009, 206 (02) : 335 - 339
  • [28] Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease
    Forst, T.
    Karagiannis, E.
    Luebben, G.
    Hohberg, C.
    Schoendorf, T.
    Dikta, G.
    Drexler, M.
    Morcos, A.
    Daenschel, W.
    Borchert, M.
    Pfuetzner, A.
    ATHEROSCLEROSIS, 2008, 197 (01) : 311 - 317
  • [29] Resveratrol as an Anti-inflammatory Agent in Coronary Artery Disease: A Systematic Review, Meta-Analysis and Meta-Regression
    Damay, Vito A.
    Ivan, Ignatius
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2024, 30 (10) : 927 - 937
  • [30] Anti-inflammatory medications for the treatment of mental disorders: A scoping review
    Fitton, Rebecca
    Sweetman, Jennifer
    Heseltine-Carp, William
    van der Feltz-Cornelis, Christina
    BRAIN BEHAVIOR & IMMUNITY-HEALTH, 2022, 26
12345